Of them, genetically-predicted plasma soluble IL6 receptor (sIL6R), an IL6 signaling biomarker, showed robust evidence for an inverse association with CAD [36] and stroke [60] supporting a key role of inflammation in CVD which has also supportive RCT evidence [94]. Here, IL6 is linked to stroke disorder.